← Eichor
Study identifier: NCT07429773 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP

Condition: Endometriosis · Chronic Pelvic Pain Syndrome  ·  Sponsor: Centre Hospitalier Universitaire de Nice

PhaseNA
Planned participants120
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersNo

About this study

Chronic pelvic pain (CPP) affects more than one in four women. An immune imbalance in the Th1/Th2 balance has been reported in multiple CPP situations, particularly in patients with endometriosis, but with mixed results. The use of a functional immune test, already validated in previous indications and particularly in infertility, could simulate an immune stimulation similar to that of painful attacks.

This description comes directly from the study's public registry record.

Talk to the study team

Pierre-Alexis GAUCI, MD  ·  04 92 03 61 90  ·  gauci.pa@chu-nice.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Nice - Hôpital de l'Archet 2Nice, Alpes-Maritimes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07429773